About Anthony Ford
Form D filings for Avalor Therapeutics in 2023 list Anthony Ford as director.
Anthony Ford first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Ford in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anthony Ford works with at each company, as listed on that company's latest Form D.
Avalor Therapeutics, Inc. · Form D, Dec 5, 2023
WZ
William Martinez Zegarra
President and director
KW
Kenneth Wild
Director